This product is no longer available
Find similar productsInnovative MR-only simulation pelvis lets you plan radiation therapy for male and female pelvic cancer patients with soft-tissue tumors using MRI as a single-modality solution. Within just one MR exam, MR-only simulation provides excellent soft-tissue contrast for target and OAR delineation, and CT-like density information for dose calculations. This not only extends the benefits of MRI’s outstanding soft-tissue contrast to radiotherapy planning, but it also eliminates arduous, error-prone CT-MRI registration from the process, reducing uncertainties and complexity.
Anatomies |
|
---|---|
Compatibility RTdrive |
|
Compatibility with MR-based auto-contouring |
|
Density maps |
|
Anatomies |
|
---|---|
Compatibility RTdrive |
|
Compatibility with MR-based auto-contouring |
|
Density maps |
|
Compatibility |
|
---|---|
Imaging protocol |
|
MRCAT generation |
|
Export to treatment planning systems |
|
Anatomies |
|
---|---|
Compatibility RTdrive |
|
Anatomies |
|
---|---|
Compatibility RTdrive |
|
Anatomies |
|
---|---|
Compatibility RTdrive |
|
Compatibility with MR-based auto-contouring |
|
Density maps |
|
Anatomies |
|
---|---|
Compatibility RTdrive |
|
Compatibility with MR-based auto-contouring |
|
Density maps |
|
Compatibility |
|
---|---|
Imaging protocol |
|
MRCAT generation |
|
Export to treatment planning systems |
|
The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.